Trupanion (NASDAQ:TRUP) Shares Down 2.2%

Trupanion, Inc. (NASDAQ:TRUPGet Free Report)’s stock price was down 2.2% on Wednesday . The company traded as low as $21.69 and last traded at $21.69. Approximately 29,356 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 670,590 shares. The stock had previously closed at $22.17.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on TRUP shares. Stifel Nicolaus boosted their target price on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, February 16th. Evercore ISI decreased their target price on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, February 20th. Finally, Piper Sandler decreased their target price on Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a research report on Friday, April 5th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $33.20.

View Our Latest Research Report on TRUP

Trupanion Stock Down 0.8 %

The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The company’s 50-day moving average price is $26.92 and its 200 day moving average price is $27.04.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings results on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.13. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The firm had revenue of $295.50 million during the quarter, compared to analyst estimates of $289.84 million. During the same quarter in the prior year, the firm earned ($0.23) EPS. The business’s revenue for the quarter was up 20.1% compared to the same quarter last year. Sell-side analysts forecast that Trupanion, Inc. will post -0.43 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. PNC Financial Services Group Inc. grew its stake in shares of Trupanion by 12.1% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,340 shares of the financial services provider’s stock valued at $209,000 after acquiring an additional 253 shares during the period. Snider Financial Group grew its stake in shares of Trupanion by 10.0% during the 1st quarter. Snider Financial Group now owns 2,889 shares of the financial services provider’s stock valued at $257,000 after acquiring an additional 263 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Trupanion by 3.0% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 10,828 shares of the financial services provider’s stock valued at $652,000 after acquiring an additional 314 shares during the period. Royal Bank of Canada grew its stake in shares of Trupanion by 0.5% during the 4th quarter. Royal Bank of Canada now owns 76,201 shares of the financial services provider’s stock valued at $2,325,000 after acquiring an additional 362 shares during the period. Finally, Captrust Financial Advisors grew its stake in shares of Trupanion by 45.2% during the 2nd quarter. Captrust Financial Advisors now owns 1,297 shares of the financial services provider’s stock valued at $78,000 after acquiring an additional 404 shares during the period.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.